Meet the MedCity Media Team

And take 2 minutes to help us make MedCityNews.com better for you.

Every year, we ask you to tell us a little about yourself (anonymously) to help us create better, more relevant content and features for you. We consider every response and very much appreciate you taking the time to assist us.

Please click the button above to open a simple, multiple choice survey that should only take 2 minutes to complete.

Thank you,

The MedCity Media Team

Gates Foundation pumps $10M into NC nanotech company Liquidia

9:35 am by | 0 Comments

Nanotechnology company Liquidia Technologies has received a $10 million equity investment from the Bill & Melinda Gates Foundation to support vaccine development and commercialization.

The financing follows the announcement last month of a collaborative agreement with the PATH Malaria Vaccine Initiative, which is working with Liquidia to develop next-generation malaria vaccines using the Morrisville, North Carolina-based company’s nanotechnology methods. Liquidia’s proprietary “PRINT” technology allows for control of particle size, shape and chemistry to optimize the delivery of medicine to cells of the human body. The technology also makes the nanoparticle manufacturing process consistent and scalable, which makes new vaccines more economically viable.

MVI also has ties to the Gates Foundation. It was established in 1999 through a $168.7 million Gates Foundation grant. The Gates Foundation investment in Liquidia is part of an initiative committing $400 million to deepen the impact of the foundation’s work. These efforts include the use of financial tools such as low-interest loans, loan guarantees and equity investments to finance the work of select organizations that fall within its focus areas.

Advertisement

“This unique investment partnership will help us advance vaccine development as part of our commitment to help research, develop and deliver vaccines for the world’s poorest countries,” Doug Holtzman, deputy director for the infectious diseases team at Gates Foundation said in a prepared statement.

Privately held Liquidia has now raised nearly $60 million in equity financing, including a $25 million series C round that closed last April. Its investors include venture capital firms Canaan Partners, New Enterprise Associates, Morningside Venture Investments Limited, Pappas Ventures and Firelake Capital, as well as  Wilmington, North Carolina-based clinical research organization PPD (NYSE:PPDI).

Enhanced by Zemanta

Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

By Frank Vinluan

Frank Vinluan is the North Carolina Bureau Chief for MedCity News.
More posts by Author

0 comments